Roche launches R&D Institute in France
June 24, 2011Research and Development Roche, translational research
Roche has launched a new R&D Institute in France, furthering its links with academic centres in the country. The Institute, …
Succinct Communications boosts team
June 24, 2011Medical Communications appointment, medical communications
Succinct Healthcare Communications has strengthened its team with four new appointments.Andrea Scales joins Amersham, UK-based agency as editorial assistant, James …
Service Insight: Creative consumer communications and pharma
June 24, 2011Medical Communications Service Insight, advertising, creativity, fmcg
SERVICE INSIGHTI arrived in healthcare communications having spent 12 years as a creative PR consultant within the FMCG and technology …
Menarini pilots UK gout awareness campaign
June 23, 2011Medical Communications Menarini, disease awareness, disease awareness campaigns
A. Menarini Pharma UK has piloted a new gout awareness campaign in the North East and is preparing to give …
Service Insight: Keeping up with changes in the NHS
June 23, 2011Sales and Marketing Service Insight
SERVICE INSIGHT
John Burt takes on leadership of PolyTherics
June 23, 2011Research and Development appointment, research and development
PolyTherics has promoted John Burt from chief business officer to chief executive.Prior to joining PolyTherics, which applies precision chemistry to …
Merck scraps MS pill cladribine
June 23, 2011Research and Development, Sales and Marketing Cladribine, Merck KGaA, Movectro, multiple sclerosis
Merck KGaA has pulled all pending applications for its multiple sclerosis pill Movectro and will withdraw it from the markets …
Sanofi to boost early-stage research with ‘real world’ evidence
June 23, 2011Research and Development Sanofi, patient data, pharma research
Sanofi is aiming to maximise its R&D investment by including ‘real world’ evidence in its product development strategy. The company …
AstraZeneca sells off dental business for $1.8bn
June 23, 2011Sales and Marketing AstraZeneca, strategy
AstraZeneca is to sell its dental products firm Astra Tech to DENTSPLY for $1.8 billion. Astra Tech comprises two business …
FDA looks to make drugs risks clearer for patients
June 22, 2011Medical Communications FDA, advertising
Potential side effects from medicines need to be presented more clearly on prescription drug advertising so patients can understand the …
European approval for BMS kidney transplant drug Nulojix
June 22, 2011Sales and Marketing BMS, EMA, Nulojix, transplant
European regulators have followed their US counterparts in granting marketing authorisation for a drug which aims to prevent kidney transplant …
FDA rejects Novartis’ Ilaris for gouty arthritis
June 22, 2011Research and Development Ilaris, Novartis, gouty arthritis
An FDA advisory panel has voted against backing Novartis’ Ilaris for gouty arthritis because of safety concerns. Ilaris (canakinumab) is …
Careers in next generation contract partnering
June 22, 2011Business Services, Manufacturing and Production, Research and Development contract manufacturing, contract research, cros
Over the past few years, a significant shift has occurred in the depth and type of relations that the pharma …
Working Life: Neurotune’s chief executive
June 22, 2011Business Services, Research and Development Working Life, recruitment
Bruno Oesch, chief executive of Swiss biopharmaceutical company Neurotune, talks to Pharmafocus about being at the interface of science and …
David Kane to lead CCC’s Biosector 2
June 22, 2011Medical Communications appointment, medical communications
Chandler Chicco Companies (CCC) has appointed David Kane as managing director of its healthcare PR agency Biosector 2. He moves …
Health research charities hit back at animal rights campaign
June 21, 2011Medical Communications Animal testing, Animal tests, Cancer Research UK, animal activists
Four of the UK’s leading health research charities have hit back after being accused of funding “horrific animal experiments” by …
FDA approves Pfizer pain drug Oxecta
June 21, 2011Sales and Marketing FDA, Oxecta, Pfizer, chronic pain
The FDA has approved Pfizer and Acura’s novel pain drug Oxecta, but will require follow up studies to prove its …
NICE gains expanded role alongside value-based pricing
June 21, 2011Sales and Marketing NHS reforms, NICE, value-based pricing
NICE will be given a wider remit to oversee social care and its guidance used alongside value-based pricing as part …
NICE backs Celgene’s thalidomide and Janssen’s Velcade
June 21, 2011Sales and Marketing NICE, Thalidomide, Velcade, multiple myeloma
Celgene’s thalidomide and Janssen-Cilag’s Velcade have been given the thumbs up by NICE as a treatment for a cancer that …
Pfizer project is quality-by-design milestone for FDA and EMA
June 21, 2011Manufacturing and Production EMA, FDA, Quality by Design, pharma manufacturing news
A pilot project set up earlier this year to encourage the adoption of quality-by-design in pharmaceutical manufacturing has passed its …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
